Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q1 2024 Earnings Call Transcript
Operator: Hello, and thank you for standing by. At this time, I would like to welcome you to the Cognition Therapeutics Second Quarter 2024 Earnings Call.
Cognition Therapeutics Inc (CGTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Alyeska Investment Group Anand Parekh | 500,000 | $234,300 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 88,700 | $41,565 | -2% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 11,000 | $5,155 | 0% | |
| 4. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.75 | 5,700 | Officer, Director | 291,345 | 2024-03-14 | Filing | |
| $2.66 | 10,000 | Director | 10,000 | 2022-11-29 | Filing | |
| $2.65 | 1,871 | Large Shareholder, Director | 309,748 | 2022-11-28 | Filing | |
| $2.65 | 12,220 | Large Shareholder, Director | 2,021,906 | 2022-11-28 | Filing | |
| $2.65 | 1,973 | Large Shareholder, Director | 326,733 | 2022-11-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.00 | 90 | Large Shareholder | 385,248 | 2021-10-13 | Filing | |
| $12.00 | 90 | Director | 385,248 | 2021-10-13 | Filing | |
| $12.00 | 33 | Large Shareholder | 2,177,985 | 2021-10-13 | Filing | |
| $12.00 | 74 | Large Shareholder | 2,210,377 | 2021-10-13 | Filing | |
| $12.00 | 12 | Director | 404,439 | 2021-10-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,205,377 | $4,079,947 | 0.02% | |
| 2. | 721,554 | $1,334,875 | 0% | |
| 3. | 508,719 | $941,130 | 0.5% | |
| 4. | 219,434 | $405,953 | 0% | |
| 5. | 174,798 | $323,454 | 0% |
News See All
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to Cognition Therapeutics Fourth Quarter 2023 Earnings Call. Please note that this call is being recorded.
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen and welcome to Cognition Therapeutics Second Quarter 2023 Earnings Conference Call. My name is Jenny and I will be your conference operator today.
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2022 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Incorporated Fourth Quarter and Fiscal Year 2022 Earnings Conference Call.
Hedge Fund and Insider Trading News: Carl Icahn, TCI Fund Management, Massar Capital Management, Duet Group, Oracle Corporation (ORCL), Gitlab Inc (GTLB), and More
Billionaire Investor Carl Icahn Warns a Market Crisis is Brewing, Says Bitcoin may be an Inflation Hedge, and Reflects on His Apple and Netflix Bets in a New Interview. Here are the 7 Best Quotes.
Hedge Fund and Insider Trading News: Chase Coleman, Jim Simons, Luxury Capital Group, Jana Partners, Zoom Video Communications (ZM), DLP Resources Inc (DLPRF), and More
The past year and a half has been GREAT for hedge fund managers. After taking a temporary beating in the early days of the beginning of pandemic, hedge fund managers have bounced back in a big way.